Bio|Reflect® turns unstructured literature into organized, searchable insight that links directly to your research data.
Case study
Converting genetic resistance into metabolic yield
Salmonella infection in poultry has a detrimental effect on growth and, therefore, production. Knowledge of host resistance genes helps optimize precision management.
Using our Bio|Reflect tool, we harnessed LLMs to analyze 300k publications, identify and prioritize pathogen resistance genes in host animals, and rapidly design experiments within an agile design-make-test-validate cycle.
Let’s discuss how we can turn your data into real scientific impact.
Contact us >
Beyond animal testing in drug development
For over a century, the life sciences industry has relied on animal models as the standard for predicting drug safety and effect. But today, the industry faces a harsh reality: over 90% of new drugs that appear safe and effective in animal tests ultimately fail in human clinical trials (see for example Ineichen et al. 2024 [1] and Marshall et al. 2023[2])
How spatial biology improves clinical trial success in oncology
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard Wins 2025 BioTech Breakthrough Award For “Bioinformatics Innovation of the Year”
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.